HL7 FHIR® Profile: Pharmacy; Medication, Release 2

DESCRIPTION

This FHIR Implementation Guide has been withdrawn and should not be considered for use. The Guide underwent an HL7 ballot but the comments from that ballot have not been reconciled and no further work has been done on the guide since that ballot. For more information about this Implementation Guide, please contact the HL7 Pharmacy Workgroup (see http://www.hl7.org/Special/committees/medication/leadership.cfm). 

The US Meds Implementation Guide is based upon the FHIR STU3 specification. It promotes the consistent use of pharmacy FHIR resources in US Realm Electronic Health Record Systems (EHRs) to provide consumer and provider access to patient medications. The IG provides specific guidance on how to access a patients’ active and historical medications, including prescriptions, dispenses, administrations and statements. It also proposes future areas of guidance on how to create new outpatient prescriptions, record a dispensed medication, and mappings to support PDMP integration.

 

ALTERNATIVE NAMES

HL7 FHIR® Profile: Pharmacy; Medication, Release 2 may also go by the following names or acronyms:

TARGETS

• Quality Reporting Agencies
• Regulatory Agency
• Pharmaceutical Vendors
• EHR, PHR Vendors
• Health Care IT Vendors
• Clinical Decision Support Systems Vendors
• HIS Vendors

BENEFITS

• Supports the adoptions and implementation and use of the pharmacy FHIR resources in the US Realm

IMPLEMENTATIONS/CASE STUDIES

• Cerner
• Epic

DEVELOPMENT BACKGROUND

This guide applies the general Argonaut Project scope statement and adopts it specifically to enable a user to access, record, change a patients’ active medications as well as medication history. This covers the Meaningful Use 2015 §?170.302(d) certification requirement for EHRs.

The project work was sponsored by the ONC Office of Standards and Technology (OST) as part of its’ effort to support expanded use of HL7 FHIR standards beyond use cases defined by the ONC Certification Programs.

 

RELATED DOCUMENTS

HL7 FHIR® Profile: Pharmacy; Medication, Release 2

ADDITIONAL DETAILS

R2 of the US Meds Implementation Guide. 

Updates made:  Added mapping for Prescription Drug Monitoring Program (PDMP)

TOPIC

• Pharmacy

BALLOT TYPE

• STU

STATUS DATE

2019-07-25

RESPONSIBLE WORK GROUP

PRODUCT TYPE

• Structures

STAKEHOLDERS

• Clinical Decision Support Systems Vendors
• EHR, PHR Vendors
• Health Care IT Vendors
• HIS Vendors
• Pharmaceutical Vendors
• Quality Reporting Agencies
• Regulatory Agency

FAMILY

• FHIR

CURRENT STATE

• Retired

REALM

• Universal